Drug Type Small molecule drug |
Synonyms CT-3001 |
Target |
Mechanism GPR35 antagonists(G-protein coupled receptor 35 antagonists) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | US | 20 Sep 2024 | |
Colorectal Cancer | Phase 2 | US | 20 Sep 2024 | |
Pancreatic Ductal Adenocarcinoma | Phase 2 | US | 20 Sep 2024 |